Skip to main content

Table 3 Frequency distribution of qualitative clinical data

From: Quality of life after sialendoscopy: prospective non-randomized study

 

N

%

P-valor

Comorbidities

No

16

51.6

0.799

 

Yes

15

48.4

 

DM

No

28

93.3

 < 0.001

Yes

2

6.7

Autoimmune disease

No

28

93.3

 < 0.001

Yes

2

6.7

Actual salivary gland: parotid

No

21

67.7

0.005

Yes

10

32.3

Actual salivary gland: submand

No

10

32.3

0.005

Yes

21

67.7

Hypertension

No

21

70.0

0.002

Yes

9

30.0

Milk ingestion

No

23

79.3

 < 0.001

Yes

6

20.7

Other

No

22

78.6

 < 0.001

Yes

6

21.4

Gender

Female

18

58.1

0.204

Male

13

41.9

Sialo 7

Very/Good

25

80.6

 < 0.001

Satisf./Bad

6

19.4

Tobacco use

No

28

96.6

 < 0.001

Yes

1

3.4

Symptom: swelling

No

1

3.2

 < 0.001

Yes

30

96.8

Symptom: dry mouth

No

21

67.7

0.005

Yes

10

32.3

Symptom: salivary stone

No

11

35.5

0.022

Yes

20

64.5

Symptom: saliva changes

Não

15

48,4%

0.799

Sim

16

51,6%

Compromised side

Bilateral

6

19.4

0.004

Rigth

17

54.8

Ref

Left

8

25.8

0.020

  1. Bold values indicate the findings of statistical significance
  2. DM diabetes mellitus
  3. Sialo 7: question 7 in the Patient satisfaction post-sialendoscopy questionnaire—(PSPS questionnaire) meaning the overall satisfaction of the patient with sialendoscopy